Refine by
Radiopharmaceutical Articles & Analysis
5 articles found
Pre-Clinical Analysis Services for RDCs Preclinical research is a crucial phase in the drug development process, particularly for Radiopharmaceuticals and Drug Conjugates(RDCs). These innovative therapeutic agents hold significant promise in targeting specific diseases, particularly cancers. 1. ...
For solid tumors, using small-sized antibodies (such as single-domain antibodies or scFv) and peptide-conjugated radiopharmaceuticals has become a prominent direction in research and development due to their small size and excellent tissue penetration capabilities. ...
MIFTEC’s larger and more powerful machine currently in the design phase is expected to achieve, and even surpass, the minimum parameter of 1012for radiopharmaceutical production.” US Nuclear Corp. and MIFTEC recently signed a definitive agreement which formal-ly names US Nuclear as the exclusive manu-facturer of MIFTEC’s revolutionary medical isotope ...
The use of labelled molecules with high specificity for an organ or receptor in scintigraphy generates good local images and minimises the exposure of other organs. Octreotide was the first somatostatin synthetic analogue introduced in clinical use in the localisation of tumours with superexpression of somatostatin receptor (sstr). This work studied the labelling of HYNIC-Tyr3-octreotide with ...
The purpose of this paper is to describe the history of radiopharmaceuticals, the implications of Amendment 49 and the future needs for regulation and training in Brazil.Keywords: radiopharmacy, radiopharmaceuticals, legislation, Brazil, Amendment 49, regulation, training, nuclear ...